224 related articles for article (PubMed ID: 31811153)
1. Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells.
Wang Y; Lu T; Sun G; Zheng Y; Yang S; Zhang H; Hao S; Liu Y; Ma S; Zhang H; Ru Y; Gao S; Yen K; Cheng H; Cheng T
Nat Commun; 2019 Dec; 10(1):5594. PubMed ID: 31811153
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
[TBL] [Abstract][Full Text] [Related]
3. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
4. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming factors induce proliferation and inhibit apoptosis of melanoma cells by changing the expression of particular genes.
Wang Y; Sun HJ; Li RG; Wang XM; Cheng ZQ; Lou N
Mol Med Rep; 2019 Feb; 19(2):967-973. PubMed ID: 30569122
[TBL] [Abstract][Full Text] [Related]
6. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
Soufi A; Zaret KS
Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
[TBL] [Abstract][Full Text] [Related]
7. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
8. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
[TBL] [Abstract][Full Text] [Related]
9. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
10. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
Senís E; Mosteiro L; Grimm D; Abad M
Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
[TBL] [Abstract][Full Text] [Related]
11. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.
Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M
Science; 2016 Nov; 354(6315):. PubMed ID: 27884981
[TBL] [Abstract][Full Text] [Related]
12. H3K4 Methyltransferase Set1a Is A Key Oct4 Coactivator Essential for Generation of Oct4 Positive Inner Cell Mass.
Fang L; Zhang J; Zhang H; Yang X; Jin X; Zhang L; Skalnik DG; Jin Y; Zhang Y; Huang X; Li J; Wong J
Stem Cells; 2016 Mar; 34(3):565-80. PubMed ID: 26785054
[TBL] [Abstract][Full Text] [Related]
13. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
Cai Y; Dai X; Zhang Q; Dai Z
Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
[TBL] [Abstract][Full Text] [Related]
16. The interplay of chromatin and transcription factors during cell fate transitions in development and reprogramming.
Peñalosa-Ruiz G; Bright AR; Mulder KW; Veenstra GJC
Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194407. PubMed ID: 31356991
[TBL] [Abstract][Full Text] [Related]
17. Selective killing of leukemia cells: Yamanaka factors' new trick.
Xie H; Graf T
Stem Cells; 2020 Jul; 38(7):818-821. PubMed ID: 32159910
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
19. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
20. Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming.
Fu K; Chronis C; Soufi A; Bonora G; Edwards M; Smale ST; Zaret KS; Plath K; Pellegrini M
BMC Genomics; 2018 Dec; 19(1):956. PubMed ID: 30577748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
